Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value
Open accessThe DOI matches its OpenAlex record.
Abstract
New medical technologies are a leading driver of U.S. health care spending. This article identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases. The analysis synthesized information from peer-reviewed and other literature, a panel of technical advisors convened for the project, and 50 one-on-one expert interviews. The authors also conducted case studies of eight medical products. The following features of the U.S. health care environment tend to increase spending without also conferring major health benefits: lack of basic scientific knowledge about some disease processes, costs and risks of U.S. Food and Drug Administration (FDA) approval, limited rewards for medical products that could lower spending, treatment creep, and the medical arms race. The authors identified ten policy options that would help advance the two policy goals. Five would do so by reducing the costs and/or risks of invention and obtaining FDA approval: (1) Enable more creativity in funding basic science, (2) offer prizes for inventions, (3) buy out patents, (4) establish a public-interest investment fund, and (5) expedite FDA reviews and approvals. The other five options would do so by increasing market rewards for products: (1) Reform Medicare payment policies, (2) reform Medicare coverage policies, (3) coordinate FDA approval and Centers for Medicare & Medicaid Services coverage processes, (4) increase demand for technologies that decrease spending, and (5) produce more and more-timely technology assessments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Greenhalgh, T., Wherton, J., Papoutsi, C., Lynch, J., Hughes, G., A'Court, C., Hinder, S., Fahy, N., Procter, R., & Shaw, S. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.8775 · Cited by 2,887
“In recent years, technological innovation has moved apace and is now widely viewed as a significant potential contributor to health and wealth [10].”
Greenhalgh, T., Wherton, J., Papoutsi, C., Lynch, J., Hughes, G., A’Court, C., Hinder, S., Procter, R., & Shaw, S. (2018) · BMC Medicine · doi:10.1186/s12916-018-1050-6 · Cited by 232
Big data in digital healthcare: lessons learnt and recommendations for general practice
Agrawal, R., & Prabakaran, S. (2020) · Heredity · doi:10.1038/s41437-020-0303-2 · Cited by 218
“The UK provides an informative contrast in its NHS, a single government-run enterprise that provides free health-care at the point of service.”
BackgroundMethodInfluentialCzosnek, L., Lederman, O., Cormie, P., Zopf, E., Stubbs, B., & Rosenbaum, S. (2019) · Mental Health and Physical Activity · doi:10.1016/j.mhpa.2018.11.001 · Cited by 94
Lehoux, P., Miller, F. A., Daudelin, G., & Denis, J.-L. (2017) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2017.11 · Cited by 74
Metadata
- Authors
- Garber, S., Gates, S. M., Keeler, E. B., Vaiana, M. E., Mulcahy, A. W., Lau, C., & Kellermann, A. L.
- Venue
- Rand health quarterly
- Publisher
- RAND Health
- Published
- 2014-01-01
- Volume
- 4
- Issue
- 1
- Pages
- 3-3
- ISSN
- 2162-8254 (ISSN-L)
- OpenAlex
- W2586741452
- Cited by
- 42
- References
- 0
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value. https://app.cochat.ai/papers/10.7249/rhq-04-01-03
- The paper
- Garber, S., Gates, S. M., Keeler, E. B., Vaiana, M. E., Mulcahy, A. W., Lau, C., & Kellermann, A. L. (2014). Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value. Rand health quarterly. https://doi.org/10.7249/rhq-04-01-03
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.